Skip to navigation Skip to content



Researchers Show that “Old” Treatments Can Make “New” Myelin

April 20, 2015

A team of researchers at Case Western Research University in Ohio funded by the National Institutes of Health have shown that topical therapies used to treat skin conditions can stimulate immature cells to make new myelin in mice with MS-like disease, and in human cells isolated in the laboratory. The team is working now to understand the mechanisms for this success, so that they can develop these treatments for safe clinical study in people with MS.

Read more at Medical Xpress.

Read more about efforts to repair damage in MS.

About Multiple Sclerosis

Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body. Symptoms range from numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million people worldwide.